Innovations that extend life can generate option value and cost of experiencing future technologies. Schaeffer postdoc Meng Li developed generalizable approaches to estimating option value in cost-effectiveness analysis.
RCMAR Scientist Reginald Tucker-Seeley presents a model to consistently measure financial hardship to better inform cancer prevention research identify connections between socioeconomic circumstances and cancer risk-related behaviors and cancer screening among older adults.
Matthew Fiedler spoke at the Senate Finance Committee on May 8 about the implementation of the Medicare physician payment provisions of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).
States are addressing drug pricing issues through one of two domains. First, states are targeting drug pricing directly for both branded and generic products. Second, states are exploring topics in drug price transparency. Padula outlines state and federal policy options targeted prescription drugs that are currently being pursued.
Hospitals in Miami produced 13 percent fewer high-quality hospital stays than the U.S. average, while hospitals in Everett, Washington, a city 25 miles north of Seattle, perform over 20 percent better than average on value.
Jacobson and Alpert studied more than 2.4 million monthly claims for chemotherapy treatment and found little impact on outpatient chemotherapy treatment for the majority of oncology drugs identified as experiencing shortages between 2004 and 2011.